27 patents
Page 2 of 2
Utility
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
3 Aug 20
This invention relates to a pharmaceutical composition comprising or consisting essentially of the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD).
Benjamin Whalley, Claire Williams, Gary Stephens, Thomas Hill
Filed: 13 Sep 12
Utility
Use of cannabinoids in the treatment of epilepsy
13 Jul 20
The present invention relates to the use of cannabidiol (CBD) in the treatment of focal seizures.
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 15 Jun 16
Utility
Use of cannabinoids in the treatment of epilepsy
13 Jul 20
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey Guy
Filed: 12 Sep 19
Utility
Use of cannabinoids in the treatment of epilepsy
13 Jul 20
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 7 Nov 19
Utility
Use of cannabinoids in the treatment of mental disorders
18 May 20
This invention relates to the use of CBD to treat mental disorders.
Philip Robson, Geoffrey Guy, Stephen Wright, Emma Cheetham, Dominic Schiller
Filed: 7 Sep 16
Utility
Use of cannabinoids in the treatment of epilepsy
30 Mar 20
The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE).
Geoffrey Guy, Stephen Wright, Alice Mead, Orrin Devinsky
Filed: 8 Apr 18
Utility
Use of cannabinoids in the treatment of epilepsy
9 Mar 20
The present invention relates to the use of cannabidiol (CBD) in the treatment of Sturge Weber syndrome.
Geoffrey Guy, Stephen Wright, Alice Mead, Anne Comi
Filed: 27 Mar 17